Share
- Release Date: 29/11/12 17:39
- Summary: NTA: MLN: MLN NAV $0.8190 as at 27/11/12
- Price Sensitive: No
- Download Document 1.45KB
MLN
29/11/2012 15:39
NTA
REL: 1539 HRS Marlin Global Limited
NTA: MLN: MLN NAV $0.8190 as at 27/11/12
MLN NAV $0.8190 as at 27/11/12
Date 27/11/2012 20/11/2012
MLN NAV $0.8190 $0.8095
Share price close $0.68 $0.67
Discount 17% 17%
The above NAV is unaudited.
The net asset value per share is after deducting treasury stock (shares
acquired under the Marlin Global buyback programme).
The five largest portfolio holdings at 27 November 2012 are approximately as
follows:
Biotest (Germany) 6%
Stratec Biomedical (Germany) 4%
Wirecard (Germany) 4%
Sarin Technologies (Israel) 4%
Orthofix (United States) 4%
BACKGROUND
Marlin Global Limited ("Marlin") is a listed investment company that invests
in companies based outside of New Zealand and Australia. The investment
portfolio of Marlin is managed by Fisher Funds Management Limited, a
specialist fund manager with a track record of successful investing. Marlin
aims to offer investors competitive returns and access to a diversified
portfolio of investments through a single, investment vehicle. Marlin may
invest in listed international growth companies on any approved stock
exchange (excluding New Zealand or Australia) or unlisted international
companies not incorporated in New Zealand or Australia. The company listed on
the New Zealand Stock Exchange on 1 November 2007.
For further information please contact Marlin Global Limited, ph (09) 484
0365.
End CA:00230430 For:MLN Type:NTA Time:2012-11-29 15:39:46
